Literature DB >> 7597287

Production of cytokines by human melanoma cells and melanocytes.

S Krüger-Krasagakes1, K Krasagakis, C Garbe, T Diamantstein.   

Abstract

Experimental animal models have shown that various cytokines, depending of their specific properties, may support growth and metastasis of tumor cells or even lead to tumor rejection. The analysis of expression of cytokine genes by melanoma cell lines indicated that melanoma cells constitutively produce both autostimulatory and inhibitory cytokines. Using reverse transcriptase polymerase chain reaction analysis, simultaneous expression of several cytokines, including interleukin-1 beta (IL-1 beta), IL-6, IL-8, tumor necrosis factor-alpha, and granulocyte-macrophage colony-stimulating factor, by melanoma cells was found. The same cytokine transcripts were detected in melanocytes, suggesting that cells of the melanocytic lineage express a specific pattern of cytokines in vitro. All these cytokines are known to be able to stimulate effector cells of the host. Additionally, production of mRNA for IL-10, a cytokine with potential immunosuppressive properties, was detected in melanoma cells and melanocytes. These and other cytokines are likely to be involved in the immune response to cancer and at this time it is unknown what the net effects of multiple cytokines are on the outcome of the host response to tumor.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7597287     DOI: 10.1007/978-3-642-78771-3_11

Source DB:  PubMed          Journal:  Recent Results Cancer Res        ISSN: 0080-0015


  11 in total

1.  4-Tertiary butyl phenol exposure sensitizes human melanocytes to dendritic cell-mediated killing: relevance to vitiligo.

Authors:  Tara M Kroll; Hemamalini Bommiasamy; Raymond E Boissy; Claudia Hernandez; Brian J Nickoloff; Ruben Mestril; I Caroline Le Poole
Journal:  J Invest Dermatol       Date:  2005-04       Impact factor: 8.551

Review 2.  Therapeutic implications of autoimmune vitiligo T cells.

Authors:  Kepa Oyarbide-Valencia; Jasper G van den Boorn; Cecele J Denman; Mingli Li; Jeremy M Carlson; Claudia Hernandez; Michael I Nishimura; Pranab K Das; Rosalie M Luiten; I Caroline Le Poole
Journal:  Autoimmun Rev       Date:  2006-05-06       Impact factor: 9.754

3.  CRH inhibits NF-kappa B signaling in human melanocytes.

Authors:  Blazej Zbytek; Lawrence M Pfeffer; Andrzej T Slominski
Journal:  Peptides       Date:  2006-09-07       Impact factor: 3.750

4.  Comparison of Transcriptional Signatures of Three Staphylococcal Superantigenic Toxins in Human Melanocytes.

Authors:  Nabarun Chakraborty; Seshamalini Srinivasan; Ruoting Yang; Stacy-Ann Miller; Aarti Gautam; Leanne J Detwiler; Bonnie C Carney; Abdulnaser Alkhalil; Lauren T Moffatt; Marti Jett; Jeffrey W Shupp; Rasha Hammamieh
Journal:  Biomedicines       Date:  2022-06-14

5.  Tumour necrosis factors and several interleukins inhibit the growth and modulate the antigen expression of normal human melanocytes in vitro.

Authors:  K Krasagakis; C Garbe; J Eberle; C E Orfanos
Journal:  Arch Dermatol Res       Date:  1995       Impact factor: 3.017

6.  Melanoma exosomes promote mixed M1 and M2 macrophage polarization.

Authors:  Gina T Bardi; Mary Ann Smith; Joshua L Hood
Journal:  Cytokine       Date:  2018-02-17       Impact factor: 3.861

7.  Melanoma exosome induction of endothelial cell GM-CSF in pre-metastatic lymph nodes may result in different M1 and M2 macrophage mediated angiogenic processes.

Authors:  Joshua L Hood
Journal:  Med Hypotheses       Date:  2016-07-16       Impact factor: 1.538

8.  Tumor-associated transforming growth factor-beta and interleukin-10 contribute to a systemic Th2 immune phenotype in pancreatic carcinoma patients.

Authors:  G Bellone; A Turletti; E Artusio; K Mareschi; A Carbone; D Tibaudi; A Robecchi; G Emanuelli; U Rodeck
Journal:  Am J Pathol       Date:  1999-08       Impact factor: 4.307

9.  Innervation of melanocytes in human skin.

Authors:  M Hara; M Toyoda; M Yaar; J Bhawan; E M Avila; I R Penner; B A Gilchrest
Journal:  J Exp Med       Date:  1996-10-01       Impact factor: 14.307

10.  Immune stimulatory potential of B7.1 and B7.2 retrovirally transduced melanoma cells: suppression by interleukin 10.

Authors:  R Dummer; F Y Yue; J Pavlovic; R Geertsen; C Döhring; K Moelling; G Burg
Journal:  Br J Cancer       Date:  1998-05       Impact factor: 7.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.